Injectable Therapy for Androgenetic Alopecia: A Systematic Review

Key Points

Injectable therapy may provide cosmetic benefit in androgenetic alopecia, particularly dutasteride's effects.
Current evidence from studies is limited by small sample sizes and short follow-up periods.
Standardized randomized trials are needed to validate the routine use of injectable therapy.
Findings highlight the need for more robust clinical evidence to support effective treatment options.

Abstract

Injectable therapy may provide cosmetic benefit in AGA, particularly with dutasteride, but current evidence is limited by small sample sizes, variable protocols, and short follow-up. Standardized randomized trials are required before injectable therapy can be recommended as routine therapy.

Bookmark

Cite This Study

Beer et al. (Wed,) studied this question.

synapsesocial.com/papers/69a75c1ec6e9836116a249ba https://doi.org/https://doi.org/10.1097/dss.0000000000004999

Bookmark